Dendreon Buyout Chatter Back After Drop Under $5

Photo of Jon C. Ogg
By Jon C. Ogg Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Invalid Image
You know that if one sector has continued to consolidate through time, it is the biotech sector.  We often hear rumors about “the next biotech buyout.”  Today’s rumor mill around biotech is around Dendreon Corporation (NASDAQ: DNDN), which was just mentioned by CNBC.

The interesting issue here is that shares have been so much higher in the past that a buyout might not even be possible here.  In fact, this $5.00 stock was above $40 as recently as early 2011 before the persistent woes of PROVENGE sales have come on more and more frequently. One thing that CNBC noted is one thing we would bring up even before the rumor gambling analysts… about 27% of the float is short.  We noted just last Friday that the most recent short interest saw another gain, up to 40.8 million shares, versus 38.2 million shares on July 13.  This was the largest short interest in months.

If anyone is every worried that a buyout may come about, they may or may not speculate on the chances.  But if they are short, very few short sellers want to be short a stock that is being talked about as a buyout candidate.

Dendreon shares are now up 7.7% at $5.02 against a 52-week range of $4.17 to $17.04.   Another word of caution is needed here.  Trading volume is often bad in summer, but the volume of 4.2 million shares is still 2 million shares short of a full day’s average trading volume.  If we are going to really take buyout rumors seriously we would be looking for the move to be on much stronger volume.

JON C. OGG

Contact [email protected] for any questions or corrections.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. www.247wallst.com.

Continue Reading

Top Gaining Stocks

ABNB Vol: 15,913,532
MCHP Vol: 19,139,274
PLTR Vol: 77,244,625
MRNA Vol: 6,820,582
AXON Vol: 1,591,869

Top Losing Stocks

TTD Vol: 133,458,224
CTRA Vol: 73,319,495
AKAM Vol: 8,143,961
ZTS Vol: 12,784,553
RMD Vol: 3,810,438